Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073233 | SCV001238769 | uncertain significance | Retinal dystrophy | 2018-08-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001245929 | SCV001419253 | pathogenic | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 4187 of the USH2A protein (p.Arg4187His). This variant is present in population databases (rs147304271, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of USH2A-related conditions (PMID: 24938718, 31054281, 32050993, 32188678, 33090715; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 865757). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt USH2A protein function with a negative predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002480448 | SCV002777044 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2022-01-27 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV001073233 | SCV004707266 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Natera, |
RCV001828533 | SCV002088301 | uncertain significance | Usher syndrome type 2A | 2019-11-06 | no assertion criteria provided | clinical testing |